GENEVA, March 11 -- SCRIBE THERAPEUTICS INC. (1150 Marina Village ParkwayAlameda, California 94501) filed a patent application (PCT/US2025/044287) for "COMPOSITIONS AND METHODS FOR THE TARGETING OF CD38" on Aug 29, 2025. With publication no. WO/2026/050705, the details related to the patent application was published on Mar 05, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): WRIGHT, Addison (c/o Scribe Therapeutics Inc.1150 Marina Village ParkwayAlameda, California 94501), DENNY, Sarah (c/o Scribe Therapeutics Inc.1150 Marina Village ParkwayAlameda, California 94501), OAKES, Benjamin (c/o Scr...